Checking for early diabetes risk in people with autoimmune thyroid disease
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study checks for early signs of type 1 diabetes in people with autoimmune thyroid disease. It is a screening study that may help you understand your risk for the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have an autoimmune thyroid condition, such as Hashimoto's or Graves' disease.
- A blood test shows you have at least one thyroid antibody (TPO, TG, TRAb, or TSI).
- You have not been diagnosed with diabetes and are not on diabetes treatment.
- You are not pregnant or breastfeeding, and have not taken immune-suppressing drugs recently.
- You do not have any major heart, liver, or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people of all ages who have a positive islet autoantibody test but no diabetes symptoms yet. It aims to track them over time to learn more about how type 1 diabetes develops, which may lead to better prevention and care.
This study looks at whether people with diabetes have higher levels of a thyroid antibody, which may indicate an increased risk for thyroid problems. By participating, you can help doctors understand the connection between diabetes and thyroid health.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
This study checks for specific blood markers (“islet autoantibodies”) to find children who may be at risk for developing type 1 diabetes later, before symptoms start. It’s mainly for children who have no known diabetes yet.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
This study enrolls people with islet autoantibodies, which are early markers for type 1 diabetes. It aims to understand who develops these antibodies and how they are linked to diabetes over time. No treatment is given—you just provide blood samples and answer questions.
Hear when a new Autoimmune Thyroid Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.